Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Medipharm Labs Corp
(TSX:
LABS
)
0.0800
+0.0050 (+6.67%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Jun 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
65,269
Open
0.0750
Bid (Size)
0.0750 (7,460)
Ask (Size)
0.0800 (1,270)
Prev. Close
0.0750
Today's Range
0.0750 - 0.0800
52wk Range
0.0550 - 0.1000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
May 15, 2024
Via
Benzinga
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
March 27, 2024
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,...
Via
Benzinga
Performance
YTD
+23.08%
+23.08%
1 Month
-11.11%
-11.11%
3 Month
+14.29%
+14.29%
6 Month
+23.08%
+23.08%
1 Year
+14.29%
+14.29%
More News
Read More
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
February 07, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
November 14, 2023
Via
Benzinga
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
October 02, 2023
Via
Benzinga
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
September 20, 2023
Via
Benzinga
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
December 22, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO
November 15, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director
October 21, 2021
Via
Benzinga
MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia
August 31, 2021
Via
Benzinga
MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY
August 16, 2021
Via
Benzinga
MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License
July 14, 2021
Via
Benzinga
Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come
July 09, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma
June 08, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know
May 17, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick Pace
April 29, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Intellectual Property
Law Enforcement
Exposures
Cannabis
Intellectual Property
Legal
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market
April 13, 2021
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
